Admune Therapeutics' Acquisition

Admune Therapeutics was acquired by Novartis on October 21, 2015.

Admune Therapeutics is a clinical-stage biotech company focused on the development and delivery of cytokine therapy drugs for the treatment of various cancers. The company's goal is to provide effecti…

Articles about Admune Therapeutics' Acquisition: